Viewing Study NCT00416195


Ignite Creation Date: 2025-12-24 @ 2:02 PM
Ignite Modification Date: 2026-02-23 @ 4:55 AM
Study NCT ID: NCT00416195
Status: COMPLETED
Last Update Posted: 2014-07-11
First Post: 2006-12-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures
Sponsor: Eisai Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: E2007-G000-208
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View